Breast Cancer, Ductal Carcinoma In Situ , Inflammatory Breast Cancer , Invasive Ductal Carcinoma , Triple Negative Breast Cancer
Dr. Williams received her Degree in Medicine from Medical University of South Carolina, Charleston, SC. She did her residency and Musculoskeletal Diagnostic Imaging Program Fellowship at the University of South Florida, Morsani School of Medicine. She also did a Fellowship in Breast Imaging at Moffitt Cancer Center. She started her career at Moffitt Cancer Center in 2008 and has been an asset to the Breast Imaging team due to her meticulous attention to detail and her caring nature.
Education & Training
University of South Florida Mosani College of Medicine - Muskoskeletal Diagnostic Imaging
Moffitt Cancer Center - Breast Imaging
University of South Florida Mosani College of Medicine - Diagnostic Radiology
Falcon S, Funaro K, Williams A, Niell BL. Effect of the EQUIP initiative on additional images performed at screening mammography: a pilot study. Clin Imaging. 2021 May.73:13-17. Pubmedid: 33248358.
Soliman H, Hogue D, Han HS, Mooney B, Lima Barros Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Rosa M, Khong H, Czerniecki BJ. A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast Cancer. Clin Cancer Res. 2021 Feb.27(4):1012-1018. Pubmedid: 33219014.
Falcon S, Williams A, Weinfurtner J, Drukteinis JS. Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer. Cancer Control. 2017 Apr.24(2):125-136. Pubmedid: 28441367.
Townsend JD, Williams AR, Angel AJ, Finefrock AE, Beam CF. Preparation of benz[b]indeno[1,2-e]pyran-11(6H)-ones from dilithiated 2-indanone and lithiated methyl salicylates and lithiated methyl thiosalicylate. Synth Commun. 2000.30:689-689.
Angel J, Finefrock AE, French KL, Hurst DL, Williams AR, Rampey ME, Studer-Martinez SL, Beam CF. Preparation of 4-oxo-n-aryl-4h-1-benzothiopyran-2-acetamides from trilithiated acetoacetanilides and lithiated methyl thiosalicylate. Can J Chem. 1999 Jan.77(1):94-97.
Rampey ME, Halkyard CE, Williams AR, Angel AJ, Hurst DR, Townsend JD, Finefrock AE, Beam CF, Studer-Martinez SL. A New series of proton/charge transfer molecules: synthesis and spectral studies of 2-(5-aryl-1-carbomethoxy-1H-pyrazol-3-yl)phenols. Photochem Photobiol. 1999 Aug.70(2):176-183.
Williams AR, Angel AJ, French KL, Hurst DR, Beckman DD, Beam CF. The Preparation of 2-[4,5-dihydro-3-aryl-5-isoxazolyl]phenols from C(a),o-dilithiooximes and lithiated hydroxyaryl aldehydes. Synth Commun. 1999.29:1977.
Williams AR, Finefrock AR, Townsend JD, Angel AJ, Hurst DR, Rampey ME, Halkyard CE, Studer-Martinez SL, Beam CF. Hydroxyaryl-isoxazoles: synthesis and related studies. Chemist. 1998.75:7-7.
Angel J, Hurst DR, Williams AR, French KL, Beam CF. The Preparation of 2-(4-oxo-4H-1-benzopyran-2-yl)-1-phenylethanones by the condensation/ cyclization of dilithiated 1-benzoylacetone with lithiated methyl salicylates. Synth Commun. 1998.28:1547-1547.
French KL, Angel J, Williams AR, Hurst DR, Beam CF. A New preparation of substituted 4H-1-benzothiopyran-4-ones from C(a), n-benzoylhydrazones or C(a), n-carboalkoxyhydrazones and methyl thiosalicylate. J Heterocycl Chem. 1998.35:45-45.
Hurst DR, French KL, Angel J, Williams AR, Rampey ME, Guion TS, Chan KW, Kassis KM, Studer-Martinez SL, Beam CF. The Preparation of 4-oxo-n-aryl-4h-1-benzopyran-2-acetamides by the condensation/cyclization of trilithiated ccetoacetanilides with methyl salicylates. J Heterocycl Chem. 1998.35:1357-1357.
The Provider Rating is an average of all responses to specific care provider-related
questions from our nationally-recognized
Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our
Patient Satisfaction Survey . The comments are submitted by patients
and reflect their views and opinions. Patients are de-identified for confidentiality and
We post both positive and negative comments from the surveys. We do not post comments
that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may
risk the privacy of our patients.
A “[…]” in the comments below indicates de-identified patient information or comments that
are unrelated to the patient’s experience with the visit to the provider, such as
comments related to another provider, about the survey itself, or otherwise completely
Not all providers will have a star rating or comments. In order to ensure accuracy of our
ratings, we only display ratings for providers who have a minimum of 30 completed from
the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey
Patient Satisfaction Survey. If a provider does not have ratings or comments listed it
can be for several reasons, including:
The provider has not yet received the minimum number of patient satisfaction surveys
to be eligible for display. We require a minimum of 30 surveys before we post
results to ensure that the rating is statistically reliable and a true reflection of
He or she may be a researcher or other type of provider that does not see patients.
The provider practices in a specialty or office that does not use the specified
surveys currently used for these ratings.
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate buttonbelow. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub